Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Psyence BiomedicalPBM +9.64%14 EV-to-OCF is -2.60 as of Sep. 13, 2026. GuruFocus rates PBM with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 1,407 Biotechnology companies, Psyence Biomedical ranks worse than 55.08% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Psyence Biomedical's Enterprise Value is $21.17 Mil.
Psyence Biomedical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-8.14 Mil. Therefore, Psyence Biomedical's EV-to-OCF for today is -2.60.
The historical rank and industry rank for Psyence Biomedical's EV-to-OCF or its related term are showing as below:
PBM'
s EV-to-OCF Range Over the Past 10 Years
Min: -2.6 Med: 0 Max: -2.6
Current: -2.6
During the past 6 years, the highest EV-to-OCF of Psyence Biomedical was -2.60. The lowest was -2.60. And the median was .
PBM's EV-to-OCF is ranked worse than 55.08% of 1407
companies
in the Biotechnology industry
Industry Median: -3.39
vs PBM: -2.60
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Psyence Biomedical's PE Ratio (TTM) for today is calculated as:
Psyence Biomedical's share price for today is $5.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Psyence Biomedical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-12.560.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Psyence Biomedical EV-to-OCF Related Terms
Psyence Biomedical EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Psyence Biomedical's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Psyence Biomedical's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Psyence Biomedical EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Psyence Biomedical's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Psyence Biomedical's EV-to-OCF falls into.
Psyence Biomedical's current Enterprise Value is $21.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Psyence Biomedical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-8.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Psyence Biomedical (PBM) has a EV-to-OCF of -2.60 as of Sep. 13, 2026. According to the industry distribution chart, Psyence Biomedical ranks #775 out of 1407 companies in the Biotechnology industry, placing it in the top 55.1%.
Is Psyence Biomedical's EV-to-OCF too high?
Psyence Biomedical's current EV-to-OCF is -2.60. Based on the distribution chart, Psyence Biomedical ranks #775 out of 1407 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Psyence Biomedical has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Psyence Biomedical's EV-to-OCF compare to NRSN and PLUR?
According to the Biotechnology industry distribution chart, Psyence Biomedical ranks #775 out of 1407 companies for EV-to-OCF. This places Psyence Biomedical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Psyence Biomedical's current EV-to-OCF is -2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Psyence Biomedical stock overvalued right now?
Psyence Biomedical (PBM) has a current EV-to-OCF of -2.60. The current EV-to-OCF is -2.60. Psyence Biomedical's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Psyence Biomedical (PBM), the current EV-to-OCF is -2.60 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
14GF Score
Get the complete analysis for PBM
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBM has been successfully added to your 
